
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements. The webinar will address recent speculative claims and misinformation in the market, reaffirming the Company's confidence in its proprietary technology, robust leadership, and promising growth trajectory. ASP Isotopes will also highlight progress at its state-of-the-art isotope enrichment facilities in South Africa, where the commissioning of three key plants is underway. These include a Carbon-14 enrichment facility for healthcare and agrochemical applications, a Silicon-28 plant poised to revolutionize AI and quantum computing, and a Ytterbium-176 facility supporting cutting-edge radio-oncology therapies. Investors are encouraged to review the Company's SEC filings for detailed, verified information about its operations and vision.